Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MBCO Lifesciences
Delhi, Delhi, India
- Ownership
- Private
- Development stage
- Other
01
Overview
MBCO Lifesciences Private Limited is an active pharmaceutical company based in New Delhi, India, incorporated in 2019. The company operates primarily as a trader, wholesaler, and distributor of a diverse range of healthcare products, including pharmaceutical tablets, syrups, injections, and nutraceuticals. Its product portfolio features brands such as XTNAC (diclofenac) for pain relief, Breathonorm (montelukast and levocetirizine) for allergic rhinitis, and Motoneuron for nutritional deficiencies. MBCO Lifesciences focuses on distributing affordable, high-quality generic medicines and wellness products to meet regional healthcare needs.
- Therapeutic areas
- ImmunologyGastroenterologyNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on MBCO Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MBCO Lifesciences.